Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to -$22.7 million.

  • Fractyl Health's Cash from Operations fell 2591.61% to -$22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.0 million, marking a year-over-year decrease of 4559.46%. This contributed to the annual value of -$65.5 million for FY2024, which is 5300.42% down from last year.
  • Per Fractyl Health's latest filing, its Cash from Operations stood at -$22.7 million for Q3 2025, which was down 2591.61% from -$21.2 million recorded in Q2 2025.
  • In the past 5 years, Fractyl Health's Cash from Operations registered a high of -$9.5 million during Q1 2023, and its lowest value of -$25.1 million during Q1 2025.
  • Over the past 3 years, Fractyl Health's median Cash from Operations value was -$17.0 million (recorded in 2024), while the average stood at -$16.1 million.
  • Examining YoY changes over the last 5 years, Fractyl Health's Cash from Operations showed a top increase of 1313.98% in 2025 and a maximum decrease of 11414.91% in 2025.
  • Quarter analysis of 3 years shows Fractyl Health's Cash from Operations stood at -$10.6 million in 2023, then tumbled by 60.71% to -$17.0 million in 2024, then crashed by 33.35% to -$22.7 million in 2025.
  • Its Cash from Operations stands at -$22.7 million for Q3 2025, versus -$21.2 million for Q2 2025 and -$25.1 million for Q1 2025.